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Abstract
Background: Accumulating evidence implicates a fundamental link between the immune system and atherosclerosis. Toll-
like receptors are principal sensors of the innate immune system. Here we report an assessment of the role of the TLR2
pathway in atherosclerosis associated with a high-fat diet and/or bacteria in ApoE+/2 mice.
Methods and Results: To explore the role of TLR2 in inflammation- and infection-associated atherosclerosis, 10 week-old
ApoE+/2-TLR2+/+, ApoE+/2-TLR2+/2 and ApoE+/2-TLR22/2 mice were fed either a high fat diet or a regular chow diet. All
mice were inoculated intravenously, once per week for 24 consecutive weeks, with 50 ml live Porphyromonas gingivalis (P.g)
(107 CFU) or vehicle (normal saline). Animals were euthanized 24 weeks after the first inoculation. ApoE+/2-TLR2+/+ mice
showed a significant increase in atheromatous lesions in proximal aorta and aortic tree compared to ApoE+/2-TLR2+/2 and
ApoE+/2-TLR22/2 mice for all diet conditions. They also displayed profound changes in plaque composition, as evidenced
by increased macrophage infiltration and apoptosis, increased lipid content, and decreased smooth muscle cell mass, all
reflecting an unstable plaque phenotype. SAA levels from ApoE+/2-TLR2+/+ mice were significantly higher than from ApoE+/
2-TLR2+/2 and ApoE+/2-TLR22/2 mice. Serum cytokine analysis revealed increased levels of pro-inflammatory cytokines in
ApoE+/2-TLR2+/+ mice compared to ApoE+/2-TLR2+/2 and TLR22/2mice, irrespective of diet or bacterial challenge. ApoE+/2-
TLR2+/+ mice injected weekly for 24 weeks with FSL-1 (a TLR2 agonist) also demonstrated significant increases in
atherosclerotic lesions, SAA and serum cytokine levels compared to ApoE+/2-TLR22/2 mice under same treatment
condition. Finally, mass-spectrometry (MALDI-TOF-MS) of aortic samples analyzed by 2-dimentional gel electrophoresis
differential display, identified 6 proteins upregulated greater than 2-fold in ApoE+/2-TLR2+/+ mice fed the high fat diet and
inoculated with P.g compared to any other group.
Conclusion: Genetic deficiency of TLR2 reduces diet- and/or pathogen-associated atherosclerosis in ApoE+/2 mice, along
with differences in plaque composition suggesting greater structural stability while TLR-2 ligand-specific activation triggers
atherosclerosis. The present data offers new insights into the pathophysiological pathways involved in atherosclerosis and
paves the way for new pharmacological interventions aimed at reducing atherosclerosis.
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Introduction
Atherosclerosis is a multifactorial chronic inflammatory disease
characterized by the accumulation of cells of both the innate and
acquired immune systems within the intima of the arterial wall [1,2].
In atherosclerosis, the normal homeostatic functions of the
endothelium are altered, promoting an inflammatory response that
results in increased expression of adhesion molecules. This in turn
leads to recruitment of leukocytes, including monocytes, which
penetrate into the intima, predisposing the vessel wall to lipid
accretion [1,3,4]. Inflammatory mediators enhance uptake of
modified lipoprotein particles and formation of lipid-laden macro-
phages. The adaptive immune response in atherosclerosis is
mediated by T cells that enter the intima and secrete cytokines,
which subsequently amplify the inflammatory response and promote
the migration and proliferation of intimal smooth muscle cells. [2,5].
The innate immune system involves several different cell types,
most importantly those of the mononuclear phagocyte lineage
[6,7,8]. Macrophages and endothelial cells (EC) express receptors
that recognize a broad range of molecular patterns foreign to the
mammalian organism but commonly found on pathogens. These
molecules include lipopolysaccharides and lipoproteins from Gram-
negative bacteria, peptidoglycan and lipoteichoic acids from Gram-
positive bacteria, lipoproteins from mycoplasma, and zymosan from
yeast [9]. These pattern-recognition receptors include various
scavenger receptors (ScRs) and Toll-like receptors (TLRs).
TLRs are members of a large superfamily containing the
interleukin-1 receptors (IL-1R) that share significant homology in
their cytoplasmic domain, which is known as the Toll/IL-1R
(TIR) domain [10]. Ligation of most TLRs transmits transmem-
brane signals that activate the NF-kB and mitogen-activated
protein kinase (MAPK) pathways [8,11,12,13].
Both in vitro and in vivo knockout mouse studies have implicated
TLRs in neointima formation and intimal hyperplasia involving
modulation of inflammatory responses to exogenous and endog-
enous stimuli [14]. Although TLRs mediate protection against
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infection, various studies have demonstrated increased expression
of TLR1, 2, and 4 in human atherosclerotic lesion, mechanistically
linking TLRs, inflammation and atherosclerosis [6,15,16] with
downstream signaling of TLR directly regulating inflammatory
genes. In vitro stimulation of TLRs in human fibroblasts with a
synthetic fibroblast stimulating lipopeptide (FSL-1; Pam2CGDPK-
HPKSF) leads to activation of NF-kB and the production of
inflammatory cytokines in a MyD88-dependent manner [17,18].
Two important observations suggest TLR2 as a novel target to
consider for therapeutic intervention in atherosclerosis. One is that
TLR2 mediates responses to lipoproteins derived from multiple
pathogens. Its unique ability to heterodimerize with TLR1 or
TLR6 thus results in a relatively broad range of ligand specificity
[19,20,21] which may contribute to atherogenesis in the context of
exposure to a variety of pathogens.
The potential importance of infectious agents of oral/periodon-
tal origin, such as Porphyromonas gingivalis (P.g) in the development of
atherosclerosis has recently been described [22,23,24,25,26,27].
To our knowledge, the direct role of TLR2 in the bacteria-
enhanced atherogenic process had never been addressed and
warranted further investigation. Therefore, in the work reported
here, we examined the effect of genetic deletion of TLR2 on the
progression of atherosclerosis driven by a high fat diet and/or P. g
infection in the ApoE+/2 murine model. Stimulation by the
specific agonist FSL-1 was used to further establish the role of
TLR2 in modulating the progression of diet and/or bacteria
enhanced atherosclerosis in mice with normal expression of TLR2.
Results
Levels of Glucose, Total Serum Cholesterol, LDL, and HDL
Mice were monitored for metabolic status by measuring blood
glucose and lipids. No significant differences in body weight were
observed in mice in connection to genotype or treatment, (e.g. P. g,
FSL-1). Total serum cholesterol, LDL, HDL or glucose levels also
revealed no significant differences among ApoE+/2-TLR2+/+,
ApoE+/2-TLR2+/2 and ApoE+/2-TLR22/2 mice that received
similar treatments and were maintained on a similar diet.
However, we observed a tendency of increased cholesterol, LDL
and decreased HDL level in ApoE+/2-TLR2+/+ mice injected
with P. g as compared to vehicle injected group. Furthermore, the
lipid and glucose profiles did not reveal any differences between
mice of the same genotype that were injected with P. g or FSL-1
(supplemental data: Table S1 and Table S2).
En face and Histomorphometric Analysis of Atheroma
Lesions
Quantitative en face analysis revealed statistically significant smaller
lesions in ApoE+/2-TLR2+/2 mice compared to ApoE+/2-TLR2+/+
mice after 24 week treatments (p,0.05): High fat diet inoculated with
P. g (HP) demonstrated 12.561.7%,High fat diet injected with vehicle
(HS) 5.261.8%andChowdiet inoculatedwith P. g (CP) demonstrated
2.660.8% of the aorta occupied by lesion. Interestingly, we did not
observe any lesions on the aortic surface in ApoE+/2-TLR22/2mice,
irrespective of the diet or inoculum (Figs 1A–J). We also did not
observe any lesions in any of the mice that were maintained on a chow
diet and injected with vehicle (CS), regardless of their genetic
backgrounds. We previously observed similar results from en face
analysis performed after 14 weeks of these inoculation treatments of
mice these same three genotypes (data not shown).
Similarly, FSL-1 treatment for 24 weeks failed to induce any
atherosclerotic changes in the aortas of ApoE+/2-TLR22/2 mice
maintained on standard lab chow (data not shown). However, in
ApoE+/2-TLR2+/+ mice maintained on a high fat diet and treated
with FSL-1 for 24 weeks,11.260.6% of the aorta was covered by
lesion. In contrast, in mice maintained on standard chow, FSL-1
treatment for 24 weeks resulted in significantly smaller atheroscle-
rotic lesions that occupied only 1.94%60.39% of the aorta
(Fig. 2A). No statistically significant differences could be observed
in the extent of aortic lesions in ApoE+/2-TLR2+/+ mice injected
with P.g or FSL-1, irrespective of the diet (Fig. 2B).
Histomorphometric analysis revealed significantly smaller lesions
in the proximal aortas of ApoE+/2-TLR2+/2 mice compared to
ApoE+/2-TLR2+/+ mice and ApoE+/-TLR22/2 mice. In mice fed
with high fat diet and injected with P.g the proximal aorta occupied
by lesion was 46.266.6% in ApoE+/2-TLR2+/+, 18.662.4 in
ApoE+/2-TLR2+/2 and 3.0460.8 in ApoE+/-TLR22/2 mice. In
mice fed with high fat diet and injected with saline the proximal
aorta occupied by lesion was 22.762.9% in ApoE+/2-TLR2+/+,
11.762.5 in ApoE+/2-TLR2+/2 and 2.260.6 in ApoE+/-TLR22/2
mice. In mice fed with chow diet and injected with P.g the proximal
aorta occupied by lesion was 16.163.2% in ApoE+/2-TLR2+/+,
7.662.3 in ApoE+/2-TLR2+/2 and 1.560.5 in ApoE+/-TLR22/2
mice. (Fig. 3) Similar results were obtained at 14 weeks post
inoculation also (data not shown). However, we did not observe any
lesions in the chow-fed, vehicle-treated mice (CS), irrespective of
their TLR2 genotype. Histomorphometric analysis of the proximal
aortas revealed that 37.564.6% of the aortic lumen was occupied by
lesion in ApoE+/2-TLR2+/+ mice injected with FSL-1 and
maintained on a high fat diet, compared with only 10.461.3% of
ApoE+/2-TLR2+/+ mice kept on a chow diet (Fig 4A). No lesions
were observed in ApoE+/2-TLR22/2 mice after 24 weeks of FSL-1
injections and a standard chow diet (data not shown). Furthermore,
there was no statistically significant difference in the percentage of
aortic lumen occupied by lesions in mice injected with P. g when
compared to FSL-1 treatment, irrespective of diet (Fig 4B).
Imunohistochemical Analysis of Proximal Aorta
After establishing the involvement of TLR2 in diet/bacteria
induced atherosclerosis, we performed a detailed examination of
plaque compositions by immunofluorescence staining. Five
sections of the proximal aorta per animal (n = 8) each separated
by 80 mm, were selected and staining specific for macrophages,
smooth muscle cells, and apoptotic cells using MOMA-2, a-SMA
and TUNEL were performed, respectively. Significant differences
in the plaque composition were observed between atherosclerotic
lesions of all ApoE+/2-TLR2+/+ mice when compared to those
from ApoE+/2-TLR2+/2 and ApoE+/2-TLR22/2 mice, irrespec-
tive of the treatment. The atherosclerotic lesions in ApoE+/2-
TLR2+/+ mice exhibited a greater percentage of infiltrating
macrophages than smooth muscle cell accumulation. In contrast,
in ApoE+/2-TLR2+/2 and ApoE+/2-TLR22/2 mice, macro-
phage content was either less than or equal to the smooth muscle
cell accumulation in plaques (Figs. 5A–5G). Furthermore, the
marked increase in the inflammatory component of the lesions in
ApoE+/2-TLR2+/+mice was associated with a substantial increase
in the occurrence of apoptosis within their plaques. In ApoE+/-
TLR2+/+ mice we observed: 6.3%, 5.2% and 4.9% inflammatory
component in the HP, HS and CP groups, respectively (Figs. 5I–L)
Serum Amyloid A Level
At the conclusion of the 24 week treatment period, SAA levels
were highest in mice on high fat diets and also inoculated with P.g.
High fat mice inoculated only with saline had the next highest
SAA levels, followed by mice on a normal diet but challenged with
weekly inoculations of P.g. Mice from all genetic backgrounds
maintained on standard chow and inoculated with vehicle had the
lowest SAA levels, regardless of genotype (Fig 6A). The serum
TLR-2 Mediated Atherosclerosis
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SAA levels were undetectable in ApoE+/2-TLR22/2 mice
maintained on a chow diet and injected with FSL-1 (data not
shown). Also, there was no significant difference in serum SAA
levels between ApoE+/2-TLR2+/+ mice injected with FSL-1 when
compared to the P. g injected group, irrespective of the diet
(Fig 6B).
Serum Cytokine Levels
To further correlate the serum cytokine levels within advanced
stage atherosclerotic lesions, serum samples were analyzed for 32
cytokines. Statistical significance was evaluated by ANOVA
followed by the post-hoc Scheffe test. A level of p,0.05 was
considered significant. Significantly altered cytokine levels were
observed as a consequence of the high fat diet and of inoculation
with P. g. These are presented in supplement sheet Fig-3.
Compared to ApoE+/2-TLR2+/2 and ApoE+/2-TLR22/2 mice,
ApoE+/2-TLR2+/+ mice displayed profoundly higher levels of
most proinflammatory cytokines and chemokines, including IL-1a,
IL-1b, IL-6, IL-12p40, IL-12p70, TNF-a, MCP-1, VEGF, M-
CSF, and GM-CSF in high fat diet and/or bacterial-challenged
animals. No significant differences were observed in the cytokine
levels between all 3 genetic background mice fed the chow diet
and saline-inoculated. The most significantly elevated cytokine
levels were seen in ApoE+/2-TLR2+/+ mice fed the high fat diet
and also inoculated with P.g (HP) (Fig. 7).
Cytokine profiling in serum samples obtained from ApoE+/2-
TLR2+/+ mice treated for 24 weeks with FSL-1 or wild type P.g.
were compared. The expression of cytokines was increased with
both stimuli in ApoE+/2-TLR2+/+ stimulated with FSL-1 or wild-
type P.g. irrespective of the diet (Fig. 3 and 4 Supplemental Data
S1). FSL-1 did not stimulate cytokine expression in ApoE+/2-
TLR22/2 mice (Fig. S3 and S4 Supplemental Data S1).
Two-dimensional Protein Maps of Aortic Tissues from
ApoE+/2-TLR2+/+ and ApoE+/2-TLR22/2 Mice
Protein extracts from aortic tissues of ApoE+/2-TLR2+/+ and
ApoE+/2-TLR22/2 mice maintained on a high fat diet and/or
inoculated with P. g were separated using 2-DGE. An example of
the overall 2-DGE patterns of aortic protein extracts of ApoE+/2-
TLR2+/+ mice fed a high fat diet and inoculated with P. g is shown
in Fig 8. A total of 34 different protein spots were detected in
response to P.g challenge: 21 protein spots increased least by 2-fold
(Fig 8 red); 3 protein spot decreased at least by 2-fold (Fig 8 green)
and 10 unmatched protein spots (Fig 8 black). Out of the 21
Figure 1. P. g and/or high fat diet increases aortic atherosclerotic lesions in ApoE+/2-TLR2+/+ mice when compared to ApoE+/2-
TLR2+/2, and ApoE+/2-TLR22/2mice. En face analysis: (1A–1I): Representative en face view of aortic surface lesions in ApoE+/2-TLR2+/+, ApoE+/2-
TLR2+/2, and ApoE+/2-TLR22/2 mice after 24 weeks of treatments. (1J): Calculated percentages of aortic surface area covered by lesions after 24
weeks of treatments (bacterial challenge or vehicle control) among mice of three genotypes maintained on standard chow or high fat diets. Values
represent means6SD; *p,0.05 for ApoE+/2-TLR2+/+ mice compared to ApoE+/2-TLR2+/2 mice and **p,0.05 for ApoE+/2-TLR2+/+ mice compared to
ApoE+/2-TLR22/2 mice in the same treatment condition and maintained on the same diet. Abbreviations are as defined in the text.
doi:10.1371/journal.pone.0003204.g001
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protein spots with at least 2 fold increase 6 proteins: Vesl-2
protein, Sod-2 protein, fumarate hydratase, myosin light chain
polypeptide 3, aconitase, and gelsolin were identified (Table 1).
Out of the 10 unmatched spots a protein: Hb was identified
(table 1) only in ApoE+/2-TLR2+/+ mice maintained on the high
fat diet and inoculated with P. g. Magnified gel regions
corresponding to Hb from mice of both genotypes maintained
on high fat diets after challenge with P.g or vehicle are compared
in Figs 8A–D.
Discussion
In the present study we demonstrate that TLR2 plays an
important role in the pathogenesis of bacteria-enhanced diet-
dependent atherosclerosis in the ApoE+/2 murine model,
establishing a key link between atherosclerosis and immune
defense against foreign pathogens and/or endogenous inflamma-
tory ligands. Both en face and histomorphometric data revealed that
a greater percentage of the aorta and aortic lumen was occupied
by the atherosclerotic lesions in ApoE+/2-TLR2+/+ mice as
compared to either ApoE+/2-TLR2+/2 or ApoE+/2-TLR22/2
mice. ApoE+/2-TLR2+/+ mice fed a high fat diet and inoculated
with P. g (HP) exhibited larger lesions compared to mice fed a high
fat diet and inoculated only with saline vehicle (HS) or mice fed the
standard lab chow diet and inoculated with P. g. (CP). Increased
cholesterol, LDL and decreased HDL level seen in ApoE+/2-
TLR2+/+ mice injected with P. g in current work, corroborates well
previous studies showing that periodontal pathogens can influence
the systemic lipoprotein profile [33].
Our data support previous studies showing that both endoge-
nous (diet) and exogenous (Pam3CSK4) TLR2 ligands play
important roles in the modulation of atherosclerosis [14,28].
Indeed, mice deficient in TLR4, TLR2 and MyD88 all have
reduced atherosclerosis which establishes that TLR-dependent
pathways contribute to disease development. Although it is likely
that total ‘‘infectious burden’’ contributes to atherosclerosis
progression, endogenous ligands may also initiate and modulate
Toll-like receptor signaling pathways [29,30,31].
The unstable plaque phenotype is characterized by increased
vulnerability to rupture and thrombosis. Histologically, an
unstable plaque is identified by its thin fibrous cap, low smooth
muscle cell count, high macrophage content, increased apoptosis
and large lipid core [32,33,34,35,36]. The loss of the smooth
muscle cells in particular is thought to be detrimental for plaque
stability since most of the interstitial collagen fibers, which are
important for the tensile strength of the fibrous cap, are produced
by these cells [37]. Our detailed immunohistochemical analysis of
atherosclerotic lesions for smooth muscle cells, macrophages, and
apoptotic regions found that all the signs of plaque instability were
consistently observed in ApoE+/2-TLR2+/+ mice, while ApoE+/2-
TLR2+/2 and ApoE+/2-TLR22/2 mice showed lesions more
characteristic of stable plaque, with less macrophage content, less
apoptosis, smaller lipid cores, and higher smooth muscle cell mass
(Fig. 5). A significant increase of apoptosis in the lesions of ApoE+/
Figure 2. TLR2 activation through FSL-1 demonstrated no significant difference in aortic lesions when compared to P. g in ApoE+/2-
TLR2+/+ and ApoE+/2-TLR22/2 mice. (2A) Percentage of aortic surface area covered by lesions in chow-fed groups for mice from two genetic
backgrounds (ApoE+/2-TLR2+/+ and ApoE+/2-TLR22/2) injected with P. g or FSL-1 for 24 weeks. Values represent means6SD; *p,0.05 between
ApoE+/2-TLR2+/+ mice and ApoE+/2-TLR22/2 mice injected with P. g; **p,0.05 between ApoE+/2-TLR2+/+ mice and ApoE+/2-TLR22/2 mice injected
with FSL-1. No lesions were detected in ApoE+/2-TLR22/2mice irrespective of the treatment. (2B) Percentage of aortic surface area covered by lesions
in ApoE+/2-TLR2+/+ mice maintained on either diet and injected weekly with P. g or FSL-1 for 24 weeks. Values represent means6SD.
doi:10.1371/journal.pone.0003204.g002
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2-TLR2+/+ mice, along with upregulation of proinflammatory
cytokines which regulate the release of the matrix-degrading
proteinases and may favor the unstable plaque phenotype [38].
SAA, the mouse counterpart of human C-reactive protein, is an
acute phase reactant known as a marker for systemic inflamma-
tion. It has been demonstrated that CRP is produced in the liver in
response to IL-6, IL-1b, and TNF-a [39]. A strong association has
also been shown between circulating levels of SAA and the extent
of atherosclerosis in the aorta [23,26,27]. Our data demonstrated
significantly higher serum levels of SAA, IL-6, IL-1b, and TNF-a
in ApoE+/2-TLR2+/+ mice compared with ApoE+/2-TLR22/2
mice, irrespective of the diet or bacterial challenge treatment.
Furthermore, SAA levels significantly correlated with the extent of
aortic lesions examined after 24 weeks of challenge. Interestingly,
significantly lower levels of SAA in ApoE+/2-TLR22/2 mice
suggest that TLR2 deficiency may also lead to a lower overall
systemic inflammatory status.
We performed cytokine profiling in order to further investigate
the systemic inflammatory status associated with TLR2 deficiency
and the involvement of TLR2 in atherosclerosis. Our data show
that TLR2 elicits differential expression of inflammatory cytokines
and co-stimulatory molecules upon challenge with atherogenic
stimuli (P.g. and/or high fat diet). Maximum induction of a host of
proinflammatory cytokines (IL-1a, IL-1b, IL-6, IL-18, IFN-c, IL-
12p40, IL-12p70, TNF-a, MCP-1, VEGF, M-CSF, and GM-CSF)
was observed in ApoE+/2-TLR2+/+ mice maintained on a high fat
diet and challenged with P. g. Most of these cytokines and
chemokines are proinflammatory factors, favoring cell migration,
proliferation [40,41] and chemo-attraction of inflammatory cells,
such as monocytes/macrophages and T cells [42,43,44]. These
results further implicate an aspect of antigen-specific adaptive
immunity mostly characteristic of a Th1 response, including
cytokines IL-2, IL-18, IFNc and TNF-a [9]. The differential
cytokine induction also implies that P. g and/or a high fat diet can
activate different receptors to mediate intracellular signaling. It is
known that the formation of heterodimers between TLR2 and
other TLRs (TLR1 or TLR6) dictates the specificity of ligand
recognition, thereby diversifying the possible outcomes of TLR2
Figure 3. P.g and/or high fat diet increases atherosclerotic lesions in proximal aorta of ApoE+/2-TLR2+/+ mice when compared to
ApoE+/2-TLR2+/2, and ApoE+/2-TLR22/2 mice. Microscopic cross-sections (10 mm) of the proximal aortic root were stained with Sudan IV and
counterstained with hematoxylin to reveal lipid deposition, which was quantified by digital morphometry. (3A–D): results from mice maintained on a
standard chow diet and inoculated weekly with P. g (CP). (3E–H): results from mice maintained on a high fat diet and inoculated weekly with vehicle
(HS) (normal saline). (3I–L) results from mice maintained on a high fat diet and inoculated weekly with P. g (HP). (3D, H, l): data are presented
graphically as percentage of total lumen of the proximal aorta occupied by lesions after 24 weeks of injections. Values represent means6SD; *p,0.05
between ApoE+/2-TLR2+/+ mice and ApoE+/2-TLR2+/2 mice; **p,0.05 between ApoE+/2-TLR2+/+ mice and ApoE+/2-TLR22/2 mice in the same
condition and maintained on the same diet. Abbreviations are as defined in the text. Photomicrographs shown are representative images obtained at
the end of the 24 week treatment period. Original magnifications 206. Scale bar represents 0.5 mm.
doi:10.1371/journal.pone.0003204.g003
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activation [20]. In this context, it is noteworthy that the ApoE+/2-
TLR22/2 genotype conferred atheroprotective effects, which may
result in part from reduced systemic inflammation as shown by
reduced expression of proinflammatory cytokines and chemokines
in all treatment groups.
To further establish the role of TLR2 in modulating the
progression of atherosclerosis, we stimulated mice with the TLR2
agonist known as FSL-1. En face and histomorphometric analysis
revealed that systemic exposure to FSL-1 dramatically increased
lesion severity in a manner similar to P. g. In contrast, the absence
of TLR2 resulted in complete prevention of lesions in mice on the
chow diet and injected with FSL-1. Furthermore, the percentage
of the lesions observed both in aorta and aortic sinus were
comparable to the lesions observed in ApoE+/2-TLR2+/+ mice
injected with P. g irrespective of the diet after 24 weeks. FSL-1
stimulation also altered the systemic inflammatory status as
monitored by increased serum SAA levels in the ApoE+/2-
TLR2+/+ mice when compared to the ApoE+/2-TLR22/2 mice.
It is noteworthy that the levels of serum SAA in ApoE+/2-TLR2+/+
mice stimulated with FSL-1 were comparable to the levels
obtained when mice were challenged with P. g irrespective of the
diet, thus confirming the role of TLR2 in upregulation of systemic
inflammation produced by P. g challenge. Cytokine profiling
showed that both FSL-1 stimulation and P.g challenge resulted in a
relatively similar expression of proinflammatory cytokines.
Our expression proteomic approach extends the growing body
of literature linking TLR2 and atherogenesis by identifying
proteins involved in P. g- and/or diet-induced atherosclerosis in
ApoE+/2 mice. Using 2D gel electrophoresis (2-DGE) in
combination with mass spectrometry (MS), we found that in
ApoE+/2-TLR2+/+ mice, P. g stimulation in combination with a
high fat diet up-regulated the expression of a set of proteins (Hb,
Vesl-2 protein, Sod-2 protein, fumarate hydratase, myosin light
chain polypeptide 3, aconitase and gelsolin) compared to high fat
diet alone. Some of these proteins were found of interest in
improving our understanding of the mechanisms linking athero-
genesis to infection, inflammation, and immune response.
Hemoglobin (Hb) is known to enhance the biological function of
bacterial endotoxins [48] and therefore increased Hb can
contribute to aheightened systemic response. Furthermore in-
creased Hb content in the blood leads to increased viscosity, with
detrimental effects on blood flow. Moreover, intraplaque hemor-
rhage seen in advanced lesions also causes the deposition of Hb. In
our study, the detection of Hb only in ApoE+/2-TLR2+/+ mice fed
a high fat diet and injected with P. g indicates that elevated Hb
levels may be useful as a biomarker for an unstable plaque
Figure 4. TLR2 activation through FSL-1 demonstrated no significant difference in proximal aortic lesions when compared to P. g in
ApoE+/2-TLR2+/+ and ApoE+/2-TLR22/2 mice. Microscopic cross-sections (10 mm) of the proximal aortic root were stained with Sudan IV and
counterstained with hematoxylin to reveal lipid deposition, which was quantified by digital morphometry for samples from ApoE+/2-TLR2+/+ and
ApoE+/2-TLR22/2mice. (4A): percentage of total lumen of the proximal aorta occupied by lesions after 24 weeks of treatment in ApoE+/2-TLR2+/+ and
ApoE+/2-TLR22/2 mice maintained on a standard chow diet and injected weekly with P. g or FSL-1. Values represent means6SD; *p,0.05 for
differences between mice injected with P. g; **p,0.05 for differences between mice injected with FSL-1. No lesions were detected in ApoE+/2-TLR22/
2 mice irrespective of the treatment. (4B): percentage of total lumen of the proximal aorta occupied by lesions in ApoE+/2-TLR2+/+ mice maintained
on a chow diet or a high fat diet after 24 weeks of injections with P. g or FSL-1. Values represent means6SD.
doi:10.1371/journal.pone.0003204.g004
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phenotype. Its presumed mechanism of vascular injury would
include both oxidative heme toxicity caused by its ineffective
clearance and also the subsequent consumption of nitric oxide, an
important mediator of vascular homeostasis.
Vesl-2 (Homer 2) is a post-synaptic adaptor protein that has
been shown to be present in multiple tissues such as brain and
heart. It may be linked to atherogenesis through its associations
with glutamate receptor complexes and also the actin cytoskeleton.
These glutamate receptors are coupled with G-proteins and
activate phospholipase C, ultimately activating the IP3 receptor
(IP3R) to release intracellular calcium, which can alter the
function of ECs. Endothelial dysfunction typically results in
platelet aggregation at the damaged site. Elevated intracellular
calcium also leads to increased uptake of macromolecules in
plasma such as fibrinogen and LDL, eventually forming
atherosclerotic plaque. Thus it may be speculated that increased
vesl-2 protein in ApoE+/2-TLR2+/+ mice fed a high fat diet and
injected with P. g may lead to an increase in intracellular calcium,
contributing to the increased atherosclerosis in this group of mice.
Our observation of increased SOD-2 along with reduced
smooth muscle cell content in ApoE+/2-TLR2+/+ mice fed a high
fat diet and injected with P. g agrees well with a recent report in
which SOD-2 deficient smooth muscle cells can exhibit a
hypertrophic and hyperplastic phenotype. Thus we may speculate
that P.g challenge upregulates mitochondrial SOD-2 and affects
downstream pathways involving MAP kinases. Thus, increased
SOD-2 may play a crucial role in determining plaque phenotype
as it directly affects smooth muscle cell phenotype.
Gelsolin is an actin-binding protein that is a key regulator of
actin filament assembly and disassembly. It is regulated by Ca2+-
and polyphosphoinositide 4, 5-bisphosphate (PIP2) and plays an
important role in actin remodeling by regulating actin filament
severing and capping. It has also been shown to play a role in
apoptosis [45] and in sepsis-induced cell injury. Increased gelsolin
Figure 5. P. g and/or high fat diet results in unstable plaque in ApoE+/2-TLR2+/+ mice when compared to ApoE+/2-TLR2+/2, and
ApoE+/2-TLR22/2 mice. Representative photomicrographs of atherosclerotic plaques from the aortic sinus of ApoE+/2-TLR2+/+, ApoE+/2-TLR2+/2
and ApoE+/-TLR22/2 mice maintained on a high fat diet and inoculated weekly with P. g (HP) for 24 weeks. Stains identify sections of macrophage
infiltration (MOMA-2 red staining) (5a, 5b&5c); smooth muscle cells (a-SMA red staining) (5E, 5F&5G); TUNEL positive cells (green spots coinciding
with nuclear stain DAPI) (5I, 5J&5K). Quantitative computer-assisted image analysis (as described in Materials and Methods) was used to quantify the
percentage of macrophage-positive areas (5D), smooth muscle cell area (5H) and TUNEL/DAPI positive cells (5I) in proximal aortic lesions in ApoE+/2-
TLR2+/+, ApoE+/2-TLR2+/2 and ApoE+/-TLR22/2 mice of all the groups at the conclusion of the 24 week treatment period. Data represent means6SD;
*p,0.05 for ApoE+/2-TLR2+/+ mice compared to ApoE+/2-TLR2+/2 mice, and **p,0.05 for ApoE+/2-TLR2+/+mice compared to ApoE+/2-TLR22/2 mice
in the same treatment condition and maintained on the same diet. Abbreviations are as defined in text. Original magnifications 1006 for
macrophages and smooth muscle and 2006 for TUNEL/DAPI staining. Scale bar represents 0.5 mm.
doi:10.1371/journal.pone.0003204.g005
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activity has also been shown in failing human hearts [46] probably
in reaction to the cell injury. Thus, increased level of gelsolin seen
in ApoE+/2-TLR2+/+ mice fed a high fat diet and injected with P.
g may be linked to the increased apoptosis and atherosclerosis
observed in this group.
Aconitase and fumarate hydratase are Krebs cycle enzymes.
These enzymes area lso known to play important roles in the
response to oxidant stress, which can inactivate aconitase and
other Krebs cycle enzymes [47]. We observed increased aconitase
and fumarate hydratase levels in ApoE+/2-TLR2+/+ mice fed a
high fat diet and injected with P. g. These proteins probably
represent an adaptive response to increased oxidative stress but
they are also important predisposing factors in the progression of
the atherosclerotic process.
Taken together, our results confirm the important role for
TLR2 signaling in diet and/or bacteria enhanced atherosclerosis
in an ApoE+/2 mouse model, providing a link between innate
immunity, inflammation and atherosclerosis. Due to TLR2 central
role in the disease process, it represent a target of immunomod-
ulatory therapy with the goal of tipping the balance from excessive
chronic inflammation towards resolution of inflammation, while
not compromising host defenses or atheroprotective immune
functions. Therefore manipulation of TLR2 pathways has great
therapeutic potential. TLRs inhibitors or their associated signaling
molecules hold great promise in the prevention of atherosclerosis.
Materials and Methods
Please refer to the supplemental data and Fig. S1 and S2 for
details. Briefly, all animal protocols were approved by the Boston
University Medical Campus Institutional Animal Care and Use
Committee. To investigate the role of TLR2 in inflammation-
and/or infection-associated atherosclerosis, 10 week-old ApoE+/2-
TLR2+/+, ApoE+/2-TLR2+/2 and ApoE+/2-TLR22/2 mice
were fed either a high fat diet or a regular chow diet. All mice
were inoculated intravenously, once per week for 24 consecutive
weeks, with 50 ml live P. g (107 CFU) or vehicle (normal saline).
Animals were euthanized 24 weeks after the first inoculation.
Histomorphometric analysis of the aortic lesions and the proximal
aorta using Sudan red stain were performed. Immunofluroscent
staining for macrophage, smooth muscle cell and apoptosis were
performed on the proximal aortic sections. Metabolic profile,
Figure 6. TLR2 activation through FSL-1 demonstrated no significant difference in SAA levels when compared to P. g in ApoE+/2-
TLR2+/+ and ApoE+/2-TLR22/2 mice. (6A) SAA levels in serum samples obtained after 24 weeks of inoculations, as determined by ELISA. Data
represent means6SD; *p,0.05 between ApoE+/2-TLR2+/+mice and ApoE+/2-TLR2+/2 mice; **p,0.05 between ApoE+/2-TLR2+/+mice and ApoE+/2-
TLR22/2mice maintained under the same conditions and on the same diet. Abbreviations are as defined in the text. (6B) SAA levels in serum samples
obtained at the end of the study, determined by ELISA. Data represent means6SD in ApoE+/2-TLR2+/+ mice maintained on either standard chow or a
high fat diet, and injected weekly with P. g or FSL-1.
doi:10.1371/journal.pone.0003204.g006
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serum amyloid A and serum cytokine levels were also performed
for all the three genotypes. For the TLR2 agonist study a second
set of four week old male ApoE+/2-TLR2+/+ fed either a HFD or
a regular chow diet for 6 weeks (n = 10) were used. All mice were
inoculated intravenously, once per week for 24 consecutive weeks,
with 5 mg FSL-1in 50 ml saline or vehicle (normal saline). Animals
were euthanized 24 weeks after the first inoculation. To compare
and further establish an absolute effect of TLR2 in bacteria-
enhanced atherosclerotic lesions, a third set of experiments
involved only ApoE+/2-TLR22/2 mice fed only the standard
Figure 8. P.g and/or high fat diet demonstrated changes in the aortic protein in ApoE+/2-TLR2+/+ mice when compared to ApoE+/2-
TLR22/2 mice. Two-dimensional electrophoresis gel image of the proteins extracted from aortas (n = 5) from ApoE+/2-TLR2+/+ mice fed a high fat
diet and injected weekly with P. g. Enlarged spots representing Hb were observed in aortas proteins from ApoE+/2-TLR2+/+ mice maintained on a high
fat diet and injected with P. g (8B). Corresponding gel regions from aorta proteins from ApoE+/2-TLR2+/+ mice maintained on a high fat diet alone (8A)
or ApoE+/2-TLR22/2 mice fed a high fat diet alone (8C) or also injected with P.g. (8D) did not exhibit the spots. Gels were stained by SYPRO RUBY
stain. The spot numbers correspond to proteins listed in Table 1.
doi:10.1371/journal.pone.0003204.g008
Figure 7. P. g and/or high fat diet results in increased proinflamatory cytokines in ApoE+/2-TLR2+/+ mice when compared to ApoE+/
2-TLR2+/2, and ApoE+/2-TLR22/2mice. Serum cytokine levels (pg/ml) in mice maintained on a standard lab chow diet and inoculated weekly for
24 weeks with P. g. (Fig 7A&7B). Serum cytokine levels (pg/ml) in mice maintained on a high fat diet and injected with saline weekly for 24 weeks
(Fig 7C&7D). Serum cytokine levels (pg/ml) in mice maintained on a high fat diet and inoculated weekly for 24 weeks with P. g (Fig 7E&7F).
doi:10.1371/journal.pone.0003204.g007
Table 1. 1 Protein identified by MALDI TOF.
Spot number Protein Expectation Accession no. ApoE+/2 TLR2+/+
HFD+P.g
111,108,109 Gelsolin 5.30E-05 8606238 .2fold increase
104,95,80 Aconitase 1.20E-07 18079339 .2 fold increase
599,597,596,595 Hemoglobin 8.30E-06 31982300 Unmatched
689 SOD-2 6.05E-06 17390379 .2 fold increase
682 Vesl-2 2.00E-04 3766297 .2 fold increase
404 Fumarate hydratase 1.30E-05 33859554 .2 fold increase
417 Myosin, light polypeptide 3 5.70E-04 33563264 .2 fold increase
Identification of proteins differentially expressed in ApoE+/2-TLR2+/+ mice fed a high fat diet and inoculated with P. g as compared to other groups.
doi:10.1371/journal.pone.0003204.t001
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chow diet. Four week old ApoE+/2-TLR22/2 mice maintained
on a regular chow diet for 6 weeks (n = 10), were inoculated with
50 ml saline vehicle or 5 mg FSL-1 in 50 ml saline. All groups were
analyzed for atherosclerotic lesions, metabolic profile, serum
amyloid A and serum cytokine levels after 24 weeks of
inoculations.
Statistical Analysis
All histomorphometric measurements were made by an
examiner blinded to the identity of the samples. All quantitative
measurements were confirmed by random analysis of one fourth of
the specimens by the same examiner (R.0.92) and by another
independent examiner (a pathologist) to ensure consistency. The
intra-examiner and inter-examiner variation were each,10%. All
histomorphometric and serum assay data were analyzed by
ANOVA followed by the post-hoc Scheffe test. A level of
p,0.05 was considered significant.
Supporting Information
Data S1 Supplemental material document
Found at: doi:10.1371/journal.pone.0003204.s001 (0.08 MB
DOC)
Figure S1 Animal grouping and experimental time schedule for
P.gingivalis expeiments. Four week old male ApoE+/2-TLR2+/
+, ApoE+/2-TLR2+/2 and ApoE+/2-TLR22/2 mice were
fed either a HFD or a regular chow diet for 6 weeks (n = 8), then
inoculated once per week for 24 weeks with 50 ml of either vehicle
(normal saline) or 107 CFU) P. g while maintained on the chosen
diet. Thus, there were 4 groups for each genotype of mice: Group
1 was fed a standard chow diet and inoculated weekly with 50 ml
saline vehicle (CS); Group 2 was fed a standard chow diet and
inoculated with 50 ml (107 CFU) P. g. (CP); Group 3 was fed a
high fat diet and inoculated with 50 ml saline vehicle (HS); Group
4 was fed a high fat diet and inoculated with 50 ml (107 CFU) P. g
(HP). In summary, mice (n = 8) in each group received 24 tail vein
injections of either vehicle or P. g once weekly.
Found at: doi:10.1371/journal.pone.0003204.s002 (0.83 MB TIF)
Figure S2 Animal grouping and experimental time schedule for
FSL-1expeiments. Effects of FSL-1 were tested in two sets of
experiments. In the first, four week old male ApoE+/2-TLR2+/+
were fed either a HFD or a regular chow diet for 6 weeks (n = 10)
then inoculated once per week for 24 weeks with 50 ml of either
vehicle (normal saline) or 5 mg FSL-1 while maintained on the
chosen diet. The resulting 4 groups were: Group 1a was fed a
standard chow diet and inoculated with 50 ml saline vehicle (CS);
Group 2a was fed a standard chow diet and inoculated weekly
with 50 ml (5 mg) FSL-1; Group 3a was fed a high fat diet and
inoculated weekly with 50 ml saline vehicle (HS); Group 4a was fed
a high fat diet and inoculated with 50 ml (5 mg) FSL-1. All groups
were tested after 24 weeks of their diet and inoculation regimens.
For the second set of experiments, four week old ApoE+/2-
TLR22/2 mice maintained on only a regular chow diet for 6
weeks (n = 10), then were divided into 2 groups: Group 1b was
inoculated weekly with 50 ml vehicle saline (CS); Group 2b was
inoculated weekly with 50 ml (5 mg) FSL-1. All groups were tested
after 24 weeks of inoculations.
Found at: doi:10.1371/journal.pone.0003204.s003 (0.53 MB TIF)
Figure S3 TLR2 activation through FSL-1 demonstrated similar
expression of increased proinflamatory cytokines as compared
chow fed and injected with P. g in ApoE+/2-TLR2+/+ mice.
Serum cytokine levels (pg/ml) in ApoE+/2-TLR2+/+ mice fed a
standard chow diet and injected weekly with P. g or FSL-1. Data
represent mean+SD.
Found at: doi:10.1371/journal.pone.0003204.s004 (0.78 MB TIF)
Figure S4 TLR2 activation through FSL-1 demonstrated similar
expression of increased proinflamatory cytokines as compared
high fat fed and injected with P. g in ApoE+/2-TLR2+/+ mice.
Serum cytokine levels (pg/ml) in ApoE+/2-TLR2+/+ mice fed a
high fat diet and injected weekly with P. g or FSL-1. Data
represent mean+SD.
Found at: doi:10.1371/journal.pone.0003204.s005 (0.77 MB TIF)
Table S1 Metabolic profiles of ApoE+/2-TLR2+/+, ApoE+/
2-TLR2+/2 and ApoE+/2-TLR22/2 mice maintained on a
standard lab chow diet or a high fat diet, and injected weekly with
either saline or with P. g, at 24 weeks. *Significance between
ApoE+/2-TLR2+/+, ApoE+/2-TLR2+/2 and ApoE+/2-
TLR22/2 for respective groups. Abbreviations are as defined
in the text.
Found at: doi:10.1371/journal.pone.0003204.s006 (0.07 MB
DOC)
Table S2 Metabolic profile of ApoE+/2-TLR2+/+ and
ApoE+/2-TLR22/2 mice fed with either a standard lab chow
diet or a high fat diet, and injected weekly with either P. g or FSL-
1; measurements were obtained after 24 weeks of treatments.
Found at: doi:10.1371/journal.pone.0003204.s007 (0.04 MB
DOC)
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